UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Myers Industries
MYE
$1.29B
| $261K | ﹤0.01% |
17,968
| – | – |
|
2277
Phibro Animal Health
PAHC
$1.39B
| $261K | ﹤0.01% |
9,934
| – | – |
|
2278
Viemed Healthcare
VMD
$371M
| $261K | ﹤0.01% |
+27,300
| New | +$212K |
|
2279
Comtech Telecommunications
CMTL
$51.8M
| $260K | ﹤0.01% |
15,383
+2,372
| +18% | +$40.1K |
|
2280
Clean Energy Fuels
CLNE
$346M
| $259K | ﹤0.01% |
116,875
-111,948
| -49% | -$226K |
|
|
AZRE
2281
DELISTED
Azure Power Global Limited
AZRE
| $259K | ﹤0.01% |
16,208
-13,386
| -45% | -$201K |
|
|
HSKA
2282
DELISTED
Heska Corp
HSKA
| $259K | ﹤0.01% |
+2,776
| New | +$214K |
|
|
AMRS
2283
DELISTED
Amyris Inc.
AMRS
| $259K | ﹤0.01% |
60,570
+38,283
| +172% | +$127K |
|
|
MNK
2284
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $258K | ﹤0.01% |
96,309
+9,200
| +11% | +$27.6K |
|
|
AMAG
2285
DELISTED
AMAG Pharmaceuticals
AMAG
| $258K | ﹤0.01% |
33,708
-8,517
| -20% | -$65.2K |
|
2286
CytomX Therapeutics
CTMX
$753M
| $258K | ﹤0.01% |
30,931
+3,513
| +13% | +$32.6K |
|
2287
Heritage Insurance Holdings
HRTG
$991M
| $256K | ﹤0.01% |
19,564
-15,534
| -44% | -$182K |
|
2288
FB Financial Corp
FBK
$3.04B
| $256K | ﹤0.01% |
10,315
-57,996
| -85% | -$1.29M |
|
2289
National Presto Industries
NPK
$989M
| $255K | ﹤0.01% |
2,921
-740
| -20% | -$62.9K |
|
2290
Washington Trust Bancorp
WASH
$741M
| $255K | ﹤0.01% |
7,782
| – | – |
|
|
ATSG
2291
DELISTED
Air Transport Services Group
ATSG
| $249K | ﹤0.01% |
11,188
-813
| -7% | -$16.7K |
|
2292
Origin Bancorp
OBK
$1.66B
| $248K | ﹤0.01% |
+11,285
| New | +$231K |
|
2293
Relmada Therapeutics
RLMD
$519M
| $246K | ﹤0.01% |
+5,500
| New | +$233K |
|
2294
Cue Biopharma
CUE
$114M
| $246K | ﹤0.01% |
+334
| New | +$242K |
|
2295
Resources Connection
RGP
$145M
| $244K | ﹤0.01% |
20,371
+5,069
| +33% | +$54.9K |
|
2296
Wave Life Sciences
WVE
$1.2B
| $242K | ﹤0.01% |
+23,292
| New | +$219K |
|
2297
Peoples Bancorp
PEBO
$1.47B
| $241K | ﹤0.01% |
+11,319
| New | +$247K |
|
2298
Community Trust Bancorp
CTBI
$1.41B
| $239K | ﹤0.01% |
7,300
| – | – |
|
2299
Mercer International
MERC
$39.8M
| $239K | ﹤0.01% |
29,243
+1,421
| +5% | +$11.9K |
|
2300
Children's Place
PLCE
$59.8M
| $237K | ﹤0.01% |
+6,341
| New | +$216K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.